MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma—Trial in Progress.
暂无分享，去创建一个
A. Barzi | H. Lenz | J. Marshall | Y. Janjigian | T. Bekaii-Saab | M. Alsina | Jeeyun Lee | S. Siena | H. Chung | T. Yoshino | J. Strickler | E. Cutsem | D. Catenacci | M. Palanca-Wessels | W. Feng | J. Mayor | Y. Nakamura | M. C. Palanca-Wessels